Acad Radiol. 2010 Mar;17(3):271-6. doi: 10.1016/j.acra.2009.11.001. ABSTRACT RATIONALE AND OBJECTIVES: This report demonstrates the diagnostic potential of magnetic resonance imaging (MRI)-coupled fluorescence molecular tomography (FMT) to determine epidermal growth factor receptor (EGFR) status in brain cancer. MATERIALS AND METHODS: Two orthotopic glioma xenograft models were used in this study: one represented high EGFR expression and…Continue Reading MRI-coupled fluorescence tomography quantifies EGFR activity in brain tumors
Month: February 2010
